MedPath

Clinical trial of a new oral plaque removal device using the micro-scale mist

Phase 1
Conditions
Oral hygiene failure Aspiration pneumonia
Registration Number
JPRN-UMIN000026097
Lead Sponsor
Tohoku University Graduate School of Dentistry
Brief Summary

Plaque removal test on the tooth surface and safety assessment test on the palate and gingiva were performed on five healthy dentated chin. Regarding the effectiveness of plaque removal, reduction of plaque on the tooth surface was confirmed, but in some cases it could not be said that it is clinically adequate effect, and it is considered that investigation of injection distance and injection time is necessary from now on It was. For safety assessment, it is considered that safety can be secured under the conditions of use in this clinical trial without changing VAS or inflammatory findings in the palate, gums, gingiva and examination of the evaluation of the effectiveness of plaque removal in the palate from now on is necessary. As a future task, confirmation of effectiveness to molar parts and establishment of evaluation index at that time are necessary. No adverse events were observed in the use of this instrument.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
5
Inclusion Criteria

Not provided

Exclusion Criteria

(1) a person who has a significant malocclusions and periodontal disease (2) Persons who have periodontal diseases (periodontitis, gingivitis, etc.) of BOP (+) with periodontal pocket of 5 mm or more in both maxillary middle incisors (3) Persons with dental caries or medical history on the maxillary both-side central incisors (4) a person who has oral mucosal disease (5) those with vomiting reflex (6) Other, who one and principal investigator with systemic disease or research team members has judged it difficult to participate in test

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
(1) cleaning rate after mist injection into the upper jaw on both sides central incisor (comparison of before and after treatment) (2) assessment of pain immediately after and one day after the mist injection into the hard palate portion and the gingibal. (3) assessment of inflammation immediately after and one day after the mist injection into the hard palate portion and the gingibal.
Secondary Outcome Measures
NameTimeMethod
(1) adverse events and the failure
© Copyright 2025. All Rights Reserved by MedPath